There’s a moment that happens in almost every hospital sales process. The physician champion finishes explaining why your technology matters clinically. Everyone nods politely. The room feels optimistic. You start mentally calculating future revenue. Then somebody from finance asks: “How does this impact the budget?” And suddenly the entire energy changes. Because now nobody cares how innovative the technology is. They care whether the economics survive scrutiny from people w

Every medtech founder eventually faces the same uncomfortable question: how do we talk about what this product does without overstepping what the FDA cleared us to say? Under-claim, and you waste the evidence you spent millions to generate. Over-claim, and you invite a warning letter, a stalled hospital deal, or both. FDA clearance proves your product is safe. Your documentation proves your company is trustworthy. Here's what U.S. hospitals actually evaluate before they buy.